173 related articles for article (PubMed ID: 14747398)
21. Influence of angiotensin converting enzyme (
Ramanathan G; Ghosh S; Elumalai R; Periyasamy S; Lakkakula BV
Indian J Med Res; 2016 Jun; 143(6):748-755. PubMed ID: 27748299
[TBL] [Abstract][Full Text] [Related]
22. The intrarenal renin-angiotensin system in autosomal dominant polycystic kidney disease.
Loghman-Adham M; Soto CE; Inagami T; Cassis L
Am J Physiol Renal Physiol; 2004 Oct; 287(4):F775-88. PubMed ID: 15187005
[TBL] [Abstract][Full Text] [Related]
23. Role of chymase-dependent angiotensin II formation in regulating blood pressure in spontaneously hypertensive rats.
Kirimura K; Takai S; Jin D; Muramatsu M; Kishi K; Yoshikawa K; Nakabayashi M; Mino Y; Miyazaki M
Hypertens Res; 2005 May; 28(5):457-64. PubMed ID: 16156510
[TBL] [Abstract][Full Text] [Related]
24. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease.
Schrier RW
J Am Soc Nephrol; 2009 Sep; 20(9):1888-93. PubMed ID: 19696226
[TBL] [Abstract][Full Text] [Related]
25. Influence of ACE I/D gene polymorphism in the progression of renal failure in autosomal dominant polycystic kidney disease: a meta-analysis.
Pereira TV; Nunes AC; Rudnicki M; Magistroni R; Albertazzi A; Pereira AC; Krieger JE
Nephrol Dial Transplant; 2006 Nov; 21(11):3155-63. PubMed ID: 16935894
[TBL] [Abstract][Full Text] [Related]
26. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure.
Matsumoto T; Wada A; Tsutamoto T; Ohnishi M; Isono T; Kinoshita M
Circulation; 2003 May; 107(20):2555-8. PubMed ID: 12742989
[TBL] [Abstract][Full Text] [Related]
27. Angiotensin II-generating enzymes, angiotensin-converting enzyme (ACE) and mast cell chymase (CMA1), in gastric inflammation may be regulated by H. pylori and associated cytokines.
Carl-McGrath S; Gräntzdörffer I; Lendeckel U; Ebert MP; Röcken C
Pathology; 2009; 41(5):419-27. PubMed ID: 19424904
[TBL] [Abstract][Full Text] [Related]
28. Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation.
Dell'Italia LJ; Meng QC; Balcells E; Straeter-Knowlen IM; Hankes GH; Dillon R; Cartee RE; Orr R; Bishop SP; Oparil S
Am J Physiol; 1995 Dec; 269(6 Pt 2):H2065-73. PubMed ID: 8594918
[TBL] [Abstract][Full Text] [Related]
29. Measurement of activities in two different angiotensin II generating systems, chymase and angiotensin-converting enzyme, in the vitreous fluid of vitreoretinal diseases: a possible involvement of chymase in the pathogenesis of macular hole patients.
Maruichi M; Oku H; Takai S; Muramatsu M; Sugiyama T; Imamura Y; Minami M; Ueki M; Satoh B; Sakaguchi M; Miyazaki M; Ikeda T
Curr Eye Res; 2004; 29(4-5):321-5. PubMed ID: 15590479
[TBL] [Abstract][Full Text] [Related]
30. Changes of chymase, angiotensin converting enzyme and angiotensin II type 1 receptor expressions in the hamster heart during the development of heart failure.
Chen PM; Leng XG; Fan LL; Ma J; Wang YF; Chen LY
Chin Med J (Engl); 2005 Nov; 118(22):1886-92. PubMed ID: 16313843
[TBL] [Abstract][Full Text] [Related]
31. Localization of components of the renin-angiotensin system within the kidney.
Inagami T; Kawamura M; Naruse K; Okamura T
Fed Proc; 1986 Apr; 45(5):1414-9. PubMed ID: 3514278
[TBL] [Abstract][Full Text] [Related]
32. [Chymase-derived angiotensin II and arrhythmias after myocardial infarction].
Jin D; Takai S; Okamoto Y; Muramatsu M; Miyazaki M
Nihon Yakurigaku Zasshi; 2004 Aug; 124(2):77-82. PubMed ID: 15277725
[TBL] [Abstract][Full Text] [Related]
33. Vascular chymase: pathophysiological role and therapeutic potential of inhibition.
Doggrell SA; Wanstall JC
Cardiovasc Res; 2004 Mar; 61(4):653-62. PubMed ID: 14985062
[TBL] [Abstract][Full Text] [Related]
34. Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.
Koka V; Wang W; Huang XR; Kim-Mitsuyama S; Truong LD; Lan HY
Circulation; 2006 Mar; 113(10):1353-60. PubMed ID: 16520412
[TBL] [Abstract][Full Text] [Related]
35. Effects of the selective chymase inhibitor TEI-F00806 on the intrarenal renin-angiotensin system in salt-treated angiotensin I-infused hypertensive mice.
Ansary TM; Urushihara M; Fujisawa Y; Nagata S; Urata H; Nakano D; Hirofumi H; Kitamura K; Kagami S; Nishiyama A
Exp Physiol; 2018 Nov; 103(11):1524-1531. PubMed ID: 30137655
[TBL] [Abstract][Full Text] [Related]
36. Renal chymase-dependent pathway for angiotensin II formation mediated acute kidney injury in a mouse model of aristolochic acid I-induced acute nephropathy.
Hsieh WY; Chang TH; Chang HF; Chuang WH; Lu LC; Yang CW; Lin CS; Chang CC
PLoS One; 2019; 14(1):e0210656. PubMed ID: 30633770
[TBL] [Abstract][Full Text] [Related]
37. Increased expression of mast cell chymase in the lungs of patients with congenital heart disease associated with early pulmonary vascular disease.
Hamada H; Terai M; Kimura H; Hirano K; Oana S; Niimi H
Am J Respir Crit Care Med; 1999 Oct; 160(4):1303-8. PubMed ID: 10508822
[TBL] [Abstract][Full Text] [Related]
38. Intrarenal renin-angiotensin system activity is augmented after initiation of dialysis.
Ohashi N; Isobe S; Ishigaki S; Suzuki T; Ono M; Fujikura T; Tsuji T; Kato A; Ozono S; Yasuda H
Hypertens Res; 2017 Apr; 40(4):364-370. PubMed ID: 27761002
[TBL] [Abstract][Full Text] [Related]
39. Angiotensin II formation from ACE and chymase in human and animal hearts: methods and species considerations.
Balcells E; Meng QC; Johnson WH; Oparil S; Dell'Italia LJ
Am J Physiol; 1997 Oct; 273(4):H1769-74. PubMed ID: 9362242
[TBL] [Abstract][Full Text] [Related]
40. Reversal of left ventricular hypertrophy with angiotensin converting enzyme inhibition in hypertensive patients with autosomal dominant polycystic kidney disease.
Ecder T; Edelstein CL; Chapman AB; Johnson AM; Tison L; Gill EA; Brosnahan GM; Schrier RW
Nephrol Dial Transplant; 1999 May; 14(5):1113-6. PubMed ID: 10344347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
